Related Experiment Video
Updated: Jul 16, 2026

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
TRPV1 Activation Is Associated with Improved Mitochondrial Function and Cardioprotection in Experimental Hypertension
Angélica Ruiz-Ramírez1, Francisco Correa-Segura2, Leonardo Del Valle-Mondragón1
1Department of Pharmacology, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico.
Transient receptor potential vanilloid 1 (TRPV1) activation protects the heart during systemic arterial hypertension (SAH) by preserving mitochondrial function. Capsaicin treatment showed cardioprotective effects, suggesting TRPV1
Area of Science:
- Cardiovascular Research
- Mitochondrial Biology
- Pharmacology
Background:
- Systemic arterial hypertension (SAH) is modeled using N-nitro-L-arginine methyl ester (L-NAME), inhibiting nitric oxide (NO) synthesis and causing vascular dysfunction.
- Transient receptor potential vanilloid 1 (TRPV1) channels regulate calcium (Ca2+) flux and may influence mitochondrial health.
- TRPV1's role in cardiac protection during SAH, particularly its impact on mitochondrial function, requires further investigation.
Purpose of the Study:
- To investigate the hypothesis that TRPV1 activation mitigates cardiac damage in a rat model of SAH.
- To explore the effects of TRPV1 modulation on mitochondrial function and myocardial viability under hypertensive conditions.
Main Methods:
- Hypertension was induced in Wistar rats using L-NAME (200 mg/L) for 40 days.
- Experimental groups received capsaicin, capsazepine, or a combination during the final four days of L-NAME treatment.
- Cardiac function, myocardial viability (TTC staining), mitochondrial respiration, and apoptosis markers were assessed.
Main Results:
- Capsaicin administration demonstrated significant cardioprotective effects in L-NAME-induced hypertensive rats.
- Evidence suggests TRPV1 activation contributes to these protective effects, although capsazepine's partial protection indicates TRPV1-independent pathways may also be involved.
- Mitochondrial function and apoptosis-related protein levels were modulated by the treatments.
Conclusions:
- TRPV1 activation plays a role in cardioprotection during SAH, likely by maintaining mitochondrial function and redox balance.
- The study identified potential TRPV1-independent mechanisms contributing to cardiac protection in this model.
- Further research, including direct measurement of mitochondrial Ca2+ flux and genetic approaches, is needed to fully elucidate the underlying mechanisms.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Action of β1 Blockers
Cardiomyopathy III: Hypertrophic Cardiomyopathy